60 years of migraine research. Retrospective review and synopsis;60 jahre migraneforschung. Retrospektive und synopsis

Schmerz

Volumn 13, Issue 2, 1999, Pages 87-96

  Kiel, D Soyka ^a  

^a NONE   (Germany)

Author keywords

Etiology; Migraine research; Pathogenesis; Pathophysiology

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; METOPROLOL; NEUROTRANSMITTER; NORADRENALIN; PROPRANOLOL; SEROTONIN; SEROTONIN ANTAGONIST;

ADRENERGIC SYSTEM; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; HEADACHE; HUMAN; MIGRAINE; NEUROTRANSMISSION; PATHOPHYSIOLOGY; SEROTONINERGIC SYSTEM; TRIGEMINAL NERVE; VASOCONSTRICTION;

EID: 2442762439     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004820050187     Document Type: Article

References (76)

1. Afra J, Cecchini AP, De Pasqua V, Albert A, Schoenen J (1998) Visual evoked potentials during long periods of pattern-reversal stimulation in migraine. Brain 121:233-241
2. Angst J, Merikangas KR (1992) Headache and personality. Clin Neuropharmacol 15:273A-274A
3. Anthony M (1986). What is migraine? In: Carroll D, Pfaffenrath V, Sjaastad O (eds) Migraine and beta-blockade. AB Hässle, Bohusläningsens Boktr, Uddevalla, Schweden, pp 9-16
4. Barolin GS (1983) Neue Ergebnisse zu der Frage: Kopfschmerz und Depression. In: Barolin GS, Kugler J, Soyka D (Hrsg) Kopfschmerz 1983. Enke, Stuttgart, S 131-149
5. Breslau N, Andreski P (1995) Migraine, personality, and psychiatric comorbidity. Headache 35:382-386
6. Breslau N, Davis GC (1992) Migraine, major depression and panic disorder: a prospective epidemiologic study of young adults. Cephalalgia 12:85-90
7. Bruhn HD, Brand G, Henningsen KP, Christiani K (1983) Untersuchungen des Fibrinolyse-und Gerinnungssystems bei Migränepatienten im Anfall und im Intervall. In: Soyka D (Hrsg) Migräne: Pathogenese, Pharmakologie, Therapie. Enke, Stuttgart, S 46-53
8. Buzzi MG, Moskowitz MA (1992) The trigeminovascular system and migraine. Pathol Biol (Paris) 40:313-317
9. Cala LA, Mastaglia FL (1976) Computerized axial tomography findings in patients with migrainous headaches. BMJ 2:149-150
10. Clifford Rose F (1983) Biochemical findings in migraine attacks. In: Soyka D (Hrsg) Migräne: Pathogenese, Pharmakologie, Therapie. Enke, Stuttgart, S 16-22
11. Coenen HH, Diener HC (1995) Brain stem activation in spontaneous human migraine attacks. Nat Med 1:658-660
12. Couch JR (1987) Placebo effect and clinical trials in migraine therapy. Neuroepidemiology 6:178-185
13. Curran DA, Hinterberger H, Lance JW (1965) Total plasma serotonin, 5-hydroxyindole-acetic acid and p-hydroxy-m-methoxy-mandelic acid excretion in normal and migrainous subjects. Brain 88:997-1010
14. Cutrer FM, Sorensen AG, Weisskopf RM, Ostergard L, Sanchez del Rio M, Lee JL, Rosen BR, Moskowitz MA (1998) Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 43:25-31
15. Diener HC (1997) Positron emission tomography in headache. Headache 37:622-625
16. Diener HC, Brune K, Gerber, Göbel H, Pfaffenrath V (1997) Behandlung der Migräneattacke und Migräneprophylaxe. Nervenheilkunde 16:500-510
17. Ducros A, Joutel A, Vahedi K, Cecillon M, Ferreira A, Bernard E, Verier A, Echenne B, Lopez de Munain A, Bousser M, Tournier-Lasserve E (1997) Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogenity. Ann Neurol 52:885-890
18. Edvinsson, L, Goadsby PJ (1998) Neuropeptides in headache. Eur J Neurol 5:193-196
19. Evers S, Bauer B, Suhr B, Husstedt IW, Grotemeyer KH (1997) Cognitive processing in primary headache: a study on event-related potentials. Neurology 48:108-113
20. Evers S, Quibeldey F, Bauer B, Husstedt IW (1998) Dynamische Veränderungen der kognitiven Habituation während des Migräneintervalls. Schmerz 12:94
21. Fozard JR (1982) Serotonin, migraine and platelets. Prog Pharmacol 4:135-145
22. Fozard JR, Gray JA (1989) 5-HT 1C receptor activation: a key step in the initiation of migraine? Trends Pharmacol Sci 10:307-309
23. Friberg L, Olesen J, Lassen AN, Olsen T, Karle A (1994) Cerebral oxygen extraction, oxygen consumption, and regional cerebral blood flow during the aura phase of migraine. Stroke 25:974-979
24. Gardner KJ, Barmada MM, Ptacek LJ, Hoffman EP (1997) A new locus for hemiplegic migraine maps to chromosome 1q31. Neurology 49:1|231-1|238
25. Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183-187
26. Göbel H (1997) Die Kopfschmerzen. Springer, Berlin Heidelberg New York
27. Göbel H, Petersen-Braun M, Soyka D (1993) Die Prävalenz von Kopfschmerzen in Deutschland. Schmerz 7:287-297
28. Graham JR, Wolff HG (1938) Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 39:737-763
29. Hanekop GG, Ensink FBM, Bautz MT (1994) Epidemiologische Aspekte der Migräne. In: Ensink FBM, Soyka D (Hrsg) Migräne. Springer, Berlin Heidelberg New York, S 135-180
30. Hanington E, Jones RJ, Amess JAL, Wachowicz B (1981) Migraine: a platelet disorder. Lancet 2:720-723
31. Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia [Suppl 7] 8:1-96
32. Heyck H (1982) Der Kopfschmerz, 5. Aufl. Thieme, Stuttgart New York
33. Hoyer D, Clarke DE, Fozard JR et al. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203
34. Humphrey PPA (1991) 5-hydroxytryptamine and the pathophysiology of migraine. J Neurol [Suppl 1] 238:S38-S44
35. Isler H (1989) The case against the genetic hypothesis of migraine. In: Lanzi G, Balottin U, Cernibori A (eds) Headache in children and adolescents. Elsevier, Amsterdam New York, pp 195-200
36. Joutel A, Bousser MG, Biousese V, Labauge P, Chabriat H, Nmibbio H, Maciazek J, Meyer B, Bach MA, Weissenbach J, Lathrop GM, Tournier-Lasserve E (1993) A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 5:40-45
37. Kropp P, Gerber WD (1995) Contigent negative variation during migraine attack and interval: evidence for normalization of slow cortical potentials during the attack. Cephalalgia 15:123-128
38. Lassen LH, Ashina M, Christiansen L, Ulrich V, Grover R, Donaldson J, Olesen J (1998) Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia 18:27-32
39. Lauritzen M, Olesen J (1984) Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. Brain 107:447-461
40. Lauritzen M, Skyhoj Olsen T, Lassen NA, Paulson OB (1983) Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol 13:633-641
41. Leao AAP (1944) Spreading depression of activity in the cerebral cortex. J Neurophysiol 7:359-390
42. Merikangas KR, Merikangas JR, Angst J (1993) Headache syndromes and psychiatric disorders: association and familial transmission. J Psychiatr Res 27:197-210
43. Meyer JS, Takashima S, Obara K (1993) Wolff's theory of headache 50 years later. Headache Q 4:222-235
44. Moskowitz MA, Buzzi MG (1991) Neuroeffector functions of sensory fibers: implications for headache mechanisms and drug actions. J Neurol 238:18-22
45. Moskowitz MA, Henrikson BM, Markowitz S, Saito K (1988) Intra-and extracraniovascular nociceptive mechanisms and the pathogenesis of head pain. In: Olesen J, Edvinsson L (eds) Basic mechanisms of headache. Elsevier, Amsterdam New York
46. Nicolodi M, Del Bianco PL, Sicuteri F (1997) The way to serotonergic use and abuse in migraine. Int J Clin Pharmacol Res 17:79-84
47. Olesen J (1981) Focal hyperemia followed by spreading oligemia and impaired activation of rCFB in classic migraine. Ann Neurol 9:344-352
48. Olesen J (1985) Migraine and regional blood flow. Tins 8:318-321
49. Olesen J (1992) Cerebral blood flow in migraine with aura. Pathol Biol (Paris) 40:318-324
50. Olesen J, Friberg L, Olsen TS, Iversen HK, Lassen AN, Andersen AR, Karle A (1990) Timing and topography of cerebral blood flow, aura and headache during migraine attacks. Ann Neurol 28:791-798
51. Olesen J, Thomsen LL, Lassen LH, Olesen IJ (1995) The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia 15:94-100
52. Olsen TS (1993) Spreading oligemia in the migraine aura - most likely an artifact due to scattered radiation. Cephalalgia 13:86-88
53. 2+ channel gene CACNL1A4. Cell 87:543-552
54. Peroutka SJ (1997) Dopamin and migraine. Neurology 49:650-656
55. Peters UH (1982) Migräne als psychosomatische Krankheit. In: Gänshirt H, Soyka D (Hrsg) Migräne - Ursachen,Therapie. Enke, Stuttgart, S 120-129
56. Rasmussen BK (1995) Epidemiology of headache. Cephalalgia 15:44-45
57. Robbins L (1995) Anxiety, depression, and insomnia in migraine. A retrospective review of 494 patients. Headache Q 6:303-305
58. Rothlin E (1925) Über die pharmakologischen und therapeutischen Wirkungen des Ergotamins auf den Sympathicus. Klin Wochenschr 4:1|437-1|443
59. Schäfer ML (1991) Migräne und Persönlichkeit. Enke, Stuttgart
60. Schoenen J, Maertens de Noordhout A, Timsit Berthier M, Timsit M (1986) Contigent negative variation and efficacy of beta-blocking agents in migraine. Cephalalgia 6:229-233
61. Schoenen J, Wang W, Albert W, Delwaide PH (1995) Potentiation instead of habituation characterizes visual evoked potentials in migraine patients between attacks. Eur J Neurol 2:1-8
62. Selby GM, Lance JW (1960) Observation on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry 23:23-32
63. Sicuteri F, Testi A, Anselmi B (1961) Biochemical investigations in headache: increase of hydroxyindoleacetic acid excretion during migraine attacks. Int Arch Allergy Immunol 19:55-58
64. Soyka D (1983) Neurotizismus bei Migräne. In: Barolin GS, Kugler J, Soyka D (Hrsg) Kopfschmerz 1983. Enke, Stuttgart, S 88-96
65. Soyka D (1989) Kopfschmerz, 2.Aufl.VCH, Weinheim
66. Soyka D (1995) Genetik chronischer idiopathischer Kopfschmerzsyndrome. Nervenheilkunde 14:56-60
67. Soyka D (1997) Psychosomatische Aspekte bei idiopathischen Kopfschmerzsyndromen. Nervenheilkunde 16:250-256
68. Soyka D, Trettin H (1977) Rheoencephalographic investigations in migraine. Excerpta Med 427:51
69. Soyka D, Ziegler A, Gerber WD, Pfaffenrath V (1986) Die Behandlung der Migräne -Empfehlungen der Deutschen Migräne-Gesellschaft. Nervenheilkunde 5:247-251
70. Stewart WF, Lipton RB, Celentano DD, Reed ML (1992) Prevalence of migraine headache in the United States - relation to age, race, income, and other sociodemographic factors. JAMA 267:64-69
71. Thie A, Fuhlendorf A, Spitzer K, Kunze K (1990) Transcranial Doppler evaluation of common and classical migraine. Part I. Ultrasonic features during the headache-free period. Headache 30:201-208
72. Wallasch TM (1995) Neurovaskuläre Befunde bei chronischen Kopfschmerzerkrankungen. Nervenheilkunde 14:278-285
73. Wang W, Timsit-Berthier M, Schoenen J (1996) Intensity dependence of auditory evoked potentials is pronounced in migraine: an indication of cortical potentiation and low serotonergic neurotransmission? Neurology 46:1|404-1|409
74. Weiller C, May A, Limmroth V, Jüptner M, Kaube H, Schayck R van, Coenen HH, Diener HC (1955) Brain stem activation in spontaneous human migraine attacks. Nat Med 1:658-660
75. Wolff HG (1937) Personality features and reactions of subjects with migraine. Arch Neurol Psychiatry 37:895-921
76. Wolff HG (1963) Headache and other head pain. Oxford University Press, Oxford